SCHEMBL12803976

SCHEMBL12803976

COc1ccc(F)cc1NC(=S)C(F)(F)F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 3/20 0.48
▸ KMT2A Q03164 5/20 0.47
▸ MAPT P10636 3/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ HTT P42858 1/20 0.47
▸ HPGD P15428 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ HTR3E A5X5Y0 1/20 0.42
▸ HTR3B O95264 1/20 0.42
▸ HTR3A P46098 1/20 0.42
▸ HTR3D Q70Z44 1/20 0.42
▸ HTR3C Q8WXA8 1/20 0.42
▸ IRAK4 Q9NWZ3 1/20 0.42
▸ CYP1A2 P05177 3/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ PYGL P06737 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14053272 0.81 GAA (0.50) GAAKMT2AMAPTMEN1HTT
SCHEMBL31078153 0.76 ALDH1A1 (0.59) KMT2AMAPTMEN1HTTHTR3E
SCHEMBL15601956 0.74 KMT2A (0.51) GAAKMT2AMAPTMEN1HTT
SCHEMBL23512599 0.74 CYP1A2 (0.49) GAAKMT2AMAPTMEN1HTT
SCHEMBL3870167 0.74 KMT2A (0.60) GAAKMT2AMAPTMEN1HTT
SCHEMBL12804431 0.74 HPGD (0.43) GAAKMT2AMAPTHTTHPGD
SCHEMBL9383033 0.73 KMT2A (0.51) GAAKMT2AMAPTMEN1HTT
SCHEMBL8311823 0.72 APP (0.51) GAAKMT2AMAPTMEN1HTT
SCHEMBL7042391 0.71 HTT (0.47) GAAKMT2AMAPTMEN1HTT
SCHEMBL30780342 0.71 KMT2A (0.47) GAAKMT2AMAPTMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2691393-B1 NOVEL BICYCLIC PYRIDINONES PFIZER (US) 2016-09-14 — — EP disclosed
US-9067934-B2 Bicyclic pyridinones PFIZER INC. (US) 2015-06-30 — — US disclosed
US-8697673-B2 Bicyclic pyridinones PFIZER INC. (US) 2014-04-15 — — US disclosed
US-20140045790-A1 Novel Bicyclic Pyridinones PFIZER INC. (US) 2014-02-13 — — US disclosed
EP-2691393-A1 NOVEL BICYCLIC PYRIDINONES Pfizer Inc (US) 2014-02-05 — — EP disclosed
US-20120252758-A1 Novel Bicyclic Pyridinones PFIZER INC. 2012-10-04 — — US disclosed
WO-2012131539-A1 NOVEL BICYCLIC PYRIDINONES PFIZER INC. (US) 2012-10-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140045790-A1 Novel Bicyclic Pyridinones CYP2B6, CYP2C19, CYP2D6 GAA 1523/4885KMT2A 4298/4885MAPT 2099/4885
US-20120252758-A1 Novel Bicyclic Pyridinones CYP2B6, CYP2C19, CYP2D6 GAA 1523/4885KMT2A 4298/4885MAPT 2099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback